Unity Biotechnology has yet to demonstrate that its drugs can treat diseases of aging in humans but it now has
Archives
Refuge Bio Turns to China for $25M Financing of Precision CRISPR R&D
Refuge Biotechnologies, a company researching ways to use CRISPR gene editing to make cancer treatment more precise, has raised $25
3rd Innovation Sessions – Healthcare Systems and Future Therapies – 4 June 2018, Brussels, Belgium
[Source: Research & Innovation] With the participation of the Commissioner for Research, Science and Innovation, Carlos Moedas, the Portuguese Trade
BIO’s 2018 Renewable Chemical Report Now Available
In a piece for Biofuels Digest, BIO’s Executive Vice President, Industrial & Environmental Section, Brent Erickson (@BErickson_BIO) shares BIO’s 2018
Global Bilirubin Market Analysis 2018 Wuhan Yuancheng Gongchuang Technology, Chongqing …
Some of the leading manufacturers in the Bilirubin market included in the report are Maanshan Hui Zhi Biotech, Pingdingshanshi Huishengyuan
FluGen May Seek Funding from $12M Gates-Backed Flu Vaccine Challenge
Last week, the Bill and Melinda Gates Foundation announced that it plans to provide researchers with up to $12 million
A Bullish Play on Neurocrine Biosciences
Click to view a price quote on NBIX. Click to research the Drugs industry.
How GMO Answers Marked Earth Month
Sustainability is a major food trend this year – it continues to enter our conversations, whether we’re talking about reducing food waste
Biotechnology industry in Taipei will give annual output of USD 1.69 bn
Taipei City Government announced that they had launched a biotechnology industry cluster as a build-operate-transfer (BOT) project in the City’s
Bristol-Myers Latest to Drop IDO Studies in Wake of Incyte Failure
Drug giant Bristol-Myers Squibb is the latest to feel the shockwave caused by the failure of a widely watched cancer